Who Cannot Take Weight Loss Injections: Contraindications and Safety Weight loss injections, such as semaglutide (Wegovy) and liraglutide (Saxenda), are increasingly prescribed for obesity management in the UK
The other reason to stack is to cover weaknesses in a single-compound protocol
In the phase 3 SLIMMER trial published in The Lancet Diabetes & Endocrinology last year, ecnoglutide achieved weight loss of 15.1% at 48 weeks, with no evidence of a plateauing of effect, along with improvements in waist circumference, blood pressure, lipid profile, HbA1c, fasting glucose, and insulin levels
Some patients taking oral formulations report slightly increased upper gastrointestinal symptoms including heartburn or stomach discomfort compared to injectable forms, potentially related to local gastric effects before absorption
PlexusDx compounded GLP-1 optionsincluding semaglutide injection, oral semaglutide, tirzepatide injection, oral tirzepatide, and dual-compound formulationsare sourced from licensed 503A compounding pharmacies and available at transparent, accessible pricing
This establishes a final concentration of 4.0 mg/mL